Cargando…
Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis–associated interstitial lung disease trials
BACKGROUND: The extent of lung involvement visualized by high-resolution computed tomography (HRCT) is a predictor of decline in forced vital capacity (FVC) in scleroderma–interstitial lung disease. Our objective was to evaluate the performance of three different HRCT-defined staging systems in the...
Autores principales: | Khanna, Dinesh, Nagaraja, Vivek, Tseng, Chi-hong, Abtin, Fereidoun, Suh, Robert, Kim, Grace, Wells, Athol, Furst, Daniel E., Clements, Philip J., Roth, Michael D., Tashkin, Donald P., Goldin, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718035/ https://www.ncbi.nlm.nih.gov/pubmed/26704522 http://dx.doi.org/10.1186/s13075-015-0872-2 |
Ejemplares similares
-
Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient‐Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II
por: Volkmann, Elizabeth R., et al.
Publicado: (2020) -
Scleroderma-related interstitial lung disease
por: Suliman, Sally, et al.
Publicado: (2017) -
Comorbidities in interstitial lung diseases
por: Margaritopoulos, George A., et al.
Publicado: (2017) -
Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease
por: Volkmann, Elizabeth R., et al.
Publicado: (2016) -
Smoking and interstitial lung diseases
por: Margaritopoulos, George A., et al.
Publicado: (2015)